1. Home
  2. GRPN vs TBPH Comparison

GRPN vs TBPH Comparison

Compare GRPN & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

HOLD

Current Price

$16.46

Market Cap

714.1M

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.31

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRPN
TBPH
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.1M
824.9M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
GRPN
TBPH
Price
$16.46
$16.31
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$33.67
$18.40
AVG Volume (30 Days)
2.2M
344.7K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
279.13
EPS
N/A
N/A
Revenue
$2,843,877,000.00
$15,386,000.00
Revenue This Year
$5.55
$8.46
Revenue Next Year
$6.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.17
$10.42
52 Week High
$41.26
$21.03

Technical Indicators

Market Signals
Indicator
GRPN
TBPH
Relative Strength Index (RSI) 45.50 50.69
Support Level $16.05 $16.07
Resistance Level $18.81 $17.21
Average True Range (ATR) 1.70 0.32
MACD -0.41 -0.02
Stochastic Oscillator 0.49 72.57

Price Performance

Historical Comparison
GRPN
TBPH

About GRPN Groupon Inc.

Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: